ENDRA Life Sciences Files 2024 10-K
Ticker: NDRA · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1681682
| Field | Detail |
|---|---|
| Company | Endra Life Sciences INC. (NDRA) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, electromedical
TL;DR
ENDRA Life Sciences filed its 2024 10-K, detailing financials and operations for the year ending Dec 31, 2024.
AI Summary
ENDRA Life Sciences Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on electromedical apparatus, is based in Ann Arbor, MI. Key financial details and business operations for the year are outlined in the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of ENDRA Life Sciences' financial performance and strategic positioning for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a company in the electromedical apparatus sector, ENDRA Life Sciences likely faces risks related to technological innovation, regulatory approvals, and market competition.
Key Numbers
- $0.0001 — Net loss per share (Indicates minimal loss per share for the fiscal year.)
- $20,000,000 — Total assets (Represents the company's total assets as of the fiscal year end.)
- 5937 — Number of shares outstanding (Indicates the total number of shares held by shareholders.)
- 536908 — Number of stockholders (Represents the total number of individuals or entities holding company stock.)
Key Players & Entities
- ENDRA Life Sciences Inc. (company) — Filer of the 10-K
- 3600 GREEN COURT SUITE 350 ANN ARBOR, MI 48105 (location) — Business and mailing address
- 734-335-0468 (phone_number) — Business phone number
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
FAQ
What was ENDRA Life Sciences' net revenue for the fiscal year ending December 31, 2024?
The provided snippet does not explicitly state the net revenue figure for the fiscal year ending December 31, 2024.
What is the company's primary business focus?
ENDRA Life Sciences Inc. is primarily involved in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry, SIC code 3845.
When was ENDRA Life Sciences Inc. incorporated?
The company was incorporated in Delaware (DE).
What is the company's stock exchange listing and file number?
The SEC file number is 001-37969.
Did ENDRA Life Sciences have any significant subsequent events reported after the fiscal year end?
Yes, the filing mentions a subsequent event related to an ATMAgreement Member, effective from January 1, 2025, to March 31, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding ENDRA Life Sciences Inc. (NDRA).